{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Eristicophis", "Pseudocerastes", "biodiscovery", "cancer", "cytotoxic", "fibrinogenolysis", "haemotoxic", "melanoma", "thrombosis", "venom"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34199017", "DateCompleted": {"Year": "2021", "Month": "07", "Day": "26"}, "DateRevised": {"Year": "2021", "Month": "07", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "27"}], "Language": ["eng"], "ELocationID": ["6896", "10.3390/ijms22136896"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "22", "Issue": "13", "PubDate": {"Year": "2021", "Month": "Jun", "Day": "27"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Pharmacological Characterisation of <i>Pseudocerastes</i> and <i>Eristicophis</i> Viper Venoms Reveal Anticancer (Melanoma) Properties and a Potentially Novel Mode of Fibrinogenolysis.", "Abstract": {"AbstractText": ["Venoms are a rich source of potential lead compounds for drug discovery, and descriptive studies of venom form the first phase of the biodiscovery process. In this study, we investigated the pharmacological potential of crude <i>Pseudocerastes</i> and <i>Eristicophis</i> snake venoms in haematological disorders and cancer treatment. We assessed their antithrombotic potential using fibrinogen thromboelastography, fibrinogen gels with and without protease inhibitors, and colourimetric fibrinolysis assays. These assays indicated that the anticoagulant properties of the venoms are likely induced by the hydrolysis of phospholipids and by selective fibrinogenolysis. Furthermore, while most fibrinogenolysis occurred by the direct activity of snake venom metalloproteases and serine proteases, modest evidence indicated that fibrinogenolytic activity may also be mediated by selective venom phospholipases and an inhibitory venom-derived serine protease. We also found that the <i>Pseudocerastes</i> venoms significantly reduced the viability of human melanoma (MM96L) cells by more than 80%, while it had almost no effect on the healthy neonatal foreskin fibroblasts (NFF) as determined by viability assays. The bioactive properties of these venoms suggest that they contain a number of toxins suitable for downstream pharmacological development as candidates for antithrombotic or anticancer agents."]}, "AuthorList": [{"Identifier": ["0000-0002-3650-5129"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Venom Evolution Lab, School of Biological Sciences, The University of Queensland, St. Lucia, QLD 4072, Australia."}], "LastName": "Op den Brouw", "ForeName": "Bianca", "Initials": "B"}, {"Identifier": ["0000-0001-5924-9618"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran 1983969411, Iran."}, {"Identifier": [], "Affiliation": "Institute of Inorganic and Analytical Chemistry, Justus Liebig University Giessen, 35392 Giessen, Germany."}], "LastName": "Ghezellou", "ForeName": "Parviz", "Initials": "P"}, {"Identifier": ["0000-0002-8035-4719"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Snakebite Research & Interventions, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK."}], "LastName": "Casewell", "ForeName": "Nicholas R", "Initials": "NR"}, {"Identifier": ["0000-0003-0226-8257"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "H.E.J. Research Institute of Chemistry, International Centre for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi 75270, Pakistan."}], "LastName": "Ali", "ForeName": "Syed Abid", "Initials": "SA"}, {"Identifier": ["0000-0001-5752-9288"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, Yasouj University, Yasouj 57914, Iran."}], "LastName": "Fathinia", "ForeName": "Behzad", "Initials": "B"}, {"Identifier": ["0000-0001-6661-1283"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Venom Evolution Lab, School of Biological Sciences, The University of Queensland, St. Lucia, QLD 4072, Australia."}], "LastName": "Fry", "ForeName": "Bryan G", "Initials": "BG"}, {"Identifier": ["0000-0002-8164-817X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Thrombosis & Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands."}], "LastName": "Bos", "ForeName": "Mettine H A", "Initials": "MHA"}, {"Identifier": ["0000-0001-7739-080X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Translational Venomics Group, Madrid Institute for Advanced Studies in Food, E28049 Madrid, Spain."}, {"Identifier": [], "Affiliation": "Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia."}], "LastName": "Ikonomopoulou", "ForeName": "Maria P", "Initials": "MP"}], "GrantList": [{"GrantID": "2018-T1/BIO-11262", "Agency": "TALENTO Program by the Regional Madrid Government", "Country": ""}, {"GrantID": "942485", "Agency": "National Institute for Medical Research Development", "Country": ""}, {"GrantID": "NRPU No.20-3891", "Agency": "PDRF Phase II Batch-V", "Country": ""}, {"GrantID": "DP190100304", "Agency": "Australian Research Council", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Fibrinolytic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Serine Proteinase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Snake Venoms"}, {"RegistryNumber": "0", "NameOfSubstance": "Viper Venoms"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Coagulation"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects"], "DescriptorName": "Fibrinolysis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Fibrinolytic Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Serine Proteinase Inhibitors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Snake Venoms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Viper Venoms"}], "CoiStatement": "The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Casewell N.R., W\u00fcster W., Vonk F.J., Harrison R.A., Fry B.G. Complex cocktails: The evolutionary novelty of venoms. Trends Ecol. Evol. 2013;28:219\u2013229. doi: 10.1016/j.tree.2012.10.020.", "ArticleIdList": ["10.1016/j.tree.2012.10.020", "23219381"]}, {"Citation": "Junqueira-de-Azevedo I.L., Bastos C.M.V., Ho P.L., Luna M.S., Yamanouye N., Casewell N.R. Venom-related transcripts from Bothrops jararaca tissues provide novel molecular insights into the production and evolution of snake venom. Mol. Biol. Evol. 2015;32:754\u2013766. doi: 10.1093/molbev/msu337.", "ArticleIdList": ["10.1093/molbev/msu337", "PMC4327157", "25502939"]}, {"Citation": "Kini R.M. Excitement ahead: Structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon. 2003;42:827\u2013840. doi: 10.1016/j.toxicon.2003.11.002.", "ArticleIdList": ["10.1016/j.toxicon.2003.11.002", "15019485"]}, {"Citation": "Serrano S.M. The long road of research on snake venom serine proteinases. Toxicon. 2013;62:19\u201326. doi: 10.1016/j.toxicon.2012.09.003.", "ArticleIdList": ["10.1016/j.toxicon.2012.09.003", "23010164"]}, {"Citation": "Simurda T., Zolkova J., Kolkova Z., Loderer D., Dobrotova M., Skornova I., Bruncl\u00edkova M., Grendar M., Lasabova Z., Stasko J. Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia. Int. J. Hematol. 2020;111:795\u2013802. doi: 10.1007/s12185-020-02842-9.", "ArticleIdList": ["10.1007/s12185-020-02842-9", "32166693"]}, {"Citation": "Mohamed Abd El-Aziz T., Garcia Soares A., Stockand J.D. Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving. Toxins. 2019;11:564. doi: 10.3390/toxins11100564.", "ArticleIdList": ["10.3390/toxins11100564", "PMC6832721", "31557973"]}, {"Citation": "Ali S.A., Hamid F., Abbasi A., Zaidi Z.H., Shehnaz D. Pharmacological effects of the leaf-nosed viper snake (Eristocophis macmahoni) venom and its HPLC fractions. Toxicon. 1999;37:1095\u20131107. doi: 10.1016/S0041-0101(98)00243-8.", "ArticleIdList": ["10.1016/S0041-0101(98)00243-8", "10400294"]}, {"Citation": "Scarborough R.M., Rose J.W., Hsu M.A., Phillips D.R., Fried V.A., Campbell A.M., Nannizzi L., Charo I.F. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J. Biol. Chem. 1991;266:9359\u20139362. doi: 10.1016/S0021-9258(18)92826-7.", "ArticleIdList": ["10.1016/S0021-9258(18)92826-7", "2033037"]}, {"Citation": "Siddiqi A.R., Persson B., Zaidi Z.H., J\u00f6rnvall H. Characterization of two platelet aggregation inhibitor-like polypeptides from viper venom. Peptides. 1992;13:1033\u20131037. doi: 10.1016/0196-9781(92)90002-K.", "ArticleIdList": ["10.1016/0196-9781(92)90002-K", "1494485"]}, {"Citation": "Alam J.M., Ali S.A. Age-dependent variability of biochemical and biological properties in venoms of Leaf-Nose Viper snakes, Eristicophis macmahoni. Pak. J. Zool. 2001;33:173\u2013177."}, {"Citation": "Coimbra F.C., Bourke L.A., Huynh T.M., Vlecken D.H., Ghezellou P., Visser J.C., Dobson J.S., Fernandez-Rojo M.A., Ikonomopoulou M.P., Casewell N.R., et al. Extensive Variation in the Activities of Pseudocerastes and Eristicophis Viper Venoms Suggests Divergent Envenoming Strategies Are Used for Prey Capture. Toxins. 2021;13:112.", "ArticleIdList": ["PMC7913145", "33540884"]}, {"Citation": "Bdolah A. Comparison of venoms from two subspecies of the false horned viper (Pseudocerastes persicus) Toxicon. 1986;24:726\u2013729. doi: 10.1016/0041-0101(86)90036-X.", "ArticleIdList": ["10.1016/0041-0101(86)90036-X", "3775788"]}, {"Citation": "Oyama E., Takahashi H. Distribution of low molecular weight platelet aggregation inhibitors from snake venoms. Toxicon. 2007;49:293\u2013298. doi: 10.1016/j.toxicon.2006.09.027.", "ArticleIdList": ["10.1016/j.toxicon.2006.09.027", "17141819"]}, {"Citation": "Shahbazi B., Najafabadi Z.S., Goudarzi H., Sajadi M., Tahoori F., Bagheri M. Cytotoxic effects of Pseudocerastes persicus venom and its HPLC fractions on lung cancer cells. J. Venom. Anim. Toxins Incl. Trop. Dis. 2019;25:e20190009. doi: 10.1590/1678-9199-jvatitd-2019-0009.", "ArticleIdList": ["10.1590/1678-9199-jvatitd-2019-0009", "PMC6748451", "31555336"]}, {"Citation": "Batzri-Izraeli R., Bdolah A. Isolation and characterization of the main toxic fraction from the venom of the false horned viper (Pseudocerastes fieldi) Toxicon. 1982;20:867\u2013875. doi: 10.1016/0041-0101(82)90074-5.", "ArticleIdList": ["10.1016/0041-0101(82)90074-5", "7179294"]}, {"Citation": "Tsai M., Lee C., Bdolah A. Mode of neuromuscular blocking action of a toxic phospholipase A2 from Pseudocerastes fieldi (Field\u2019s horned viper) snake venom. Toxicon. 1983;21:527\u2013534. doi: 10.1016/0041-0101(83)90130-7.", "ArticleIdList": ["10.1016/0041-0101(83)90130-7", "6623493"]}, {"Citation": "Mallow D., Ludwig D., Nilson G. True Vipers: Natural History and Toxinology of Old World Vipers. Krieger Publishing Company; Malabar, FL, USA: 2003."}, {"Citation": "Ali S.A., Jackson T.N., Casewell N.R., Low D.H., Rossi S., Baumann K., Fathinia B., Visser J., Nouwens A., Hendrikx I. Extreme venom variation in Middle Eastern vipers: A proteomics comparison of Eristicophis macmahonii, Pseudocerastes fieldi and Pseudocerastes persicus. J. Proteom. 2015;116:106\u2013113. doi: 10.1016/j.jprot.2014.09.003.", "ArticleIdList": ["10.1016/j.jprot.2014.09.003", "25241240"]}, {"Citation": "Nget-Hong T., Ponnudurai G. A comparative study of the biological properties of venoms of some old world vipers (Subfamily viperinae) Int. J. Biochem. 1992;24:331\u2013336. doi: 10.1016/0020-711X(92)90266-4.", "ArticleIdList": ["10.1016/0020-711X(92)90266-4", "1733799"]}, {"Citation": "Soengas M.S., Lowe S.W. Apoptosis and melanoma chemoresistance. Oncogene. 2003;22:3138\u20133151. doi: 10.1038/sj.onc.1206454.", "ArticleIdList": ["10.1038/sj.onc.1206454", "12789290"]}, {"Citation": "Moral-Sanz J., Fernandez-Rojo M.A., Potriquet J., Mukhopadhyay P., Brust A., Wilhelm P., Smallwood T.B., Clark R.J., Fry B.G., Alewood P.F. ERK and mTORC1 Inhibitors Enhance the Anti-Cancer Capacity of the Octpep-1 Venom-Derived Peptide in Melanoma BRAF (V600E) Mutations. Toxins. 2021;13:146. doi: 10.3390/toxins13020146.", "ArticleIdList": ["10.3390/toxins13020146", "PMC7918145", "33672955"]}, {"Citation": "Ikonomopoulou M.P., Fernandez-Rojo M.A., Pineda S.S., Cabezas-Sainz P., Winnen B., Morales R.A., Brust A., S\u00e1nchez L., Alewood P.F., Ramm G.A. Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation. Sci. Rep. 2018;8:1\u201314. doi: 10.1038/s41598-018-29826-4.", "ArticleIdList": ["10.1038/s41598-018-29826-4", "PMC6070509", "30068931"]}, {"Citation": "Lassen A., Atefi M., Robert L., Wong D.J., Cerniglia M., Comin-Anduix B., Ribas A. Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma. Mol. Cancer. 2014;13:1\u201314. doi: 10.1186/1476-4598-13-83.", "ArticleIdList": ["10.1186/1476-4598-13-83", "PMC4021505", "24735930"]}, {"Citation": "Swenson S., Markland F., Jr. Snake venom fibrin (ogen) olytic enzymes. Toxicon. 2005;45:1021\u20131039. doi: 10.1016/j.toxicon.2005.02.027.", "ArticleIdList": ["10.1016/j.toxicon.2005.02.027", "15882884"]}, {"Citation": "Sanchez E.F., Flores-Ortiz R.J., Alvarenga V.G., Eble J.A. Direct Fibrinolytic Snake Venom Metalloproteinases Affecting Hemostasis: Structural, Biochemical Features and Therapeutic Potential. Toxins. 2017;9:392. doi: 10.3390/toxins9120392.", "ArticleIdList": ["10.3390/toxins9120392", "PMC5744112", "29206190"]}, {"Citation": "Boffa M.-C., Boffa G.A. A phospholipase A2 with anticoagulant activity II. Inhibition of the phospholipid activity in coagulation. Biochim. Et Biophys. Acta (BBA) Enzymol. 1976;429:839\u2013852. doi: 10.1016/0005-2744(76)90330-2.", "ArticleIdList": ["10.1016/0005-2744(76)90330-2", "5143"]}, {"Citation": "Saikia D., Thakur R., Mukherjee A.K. An acidic phospholipase A2 (RVVA-PLA2-I) purified from Daboia russelli venom exerts its anticoagulant activity by enzymatic hydrolysis of plasma phospholipids and by non-enzymatic inhibition of factor Xa in a phospholipids/Ca2+ independent manner. Toxicon. 2011;57:841\u2013850. doi: 10.1016/j.toxicon.2011.02.018.", "ArticleIdList": ["10.1016/j.toxicon.2011.02.018", "21356226"]}, {"Citation": "Wolberg A.S., Campbell R.A. Thrombin generation, fibrin clot formation and hemostasis. Transfus. Apher. Sci. 2008;38:15\u201323. doi: 10.1016/j.transci.2007.12.005.", "ArticleIdList": ["10.1016/j.transci.2007.12.005", "PMC2408736", "18282807"]}, {"Citation": "Cavigiolio G., Jayaraman S. Proteolysis of apolipoprotein A-I by secretory phospholipase A2: A new link between inflammation and atherosclerosis. J. Biol. Chem. 2014;289:10011\u201310023. doi: 10.1074/jbc.M113.525717.", "ArticleIdList": ["10.1074/jbc.M113.525717", "PMC3974973", "24523407"]}, {"Citation": "Panagides N., Jackson T.N., Ikonomopoulou M.P., Arbuckle K., Pretzler R., Yang D.C., Ali S.A., Koludarov I., Dobson J., Sanker B. How the cobra got its flesh-eating venom: Cytotoxicity as a defensive innovation and its co-evolution with hooding, aposematic marking, and spitting. Toxins. 2017;9:103. doi: 10.3390/toxins9030103.", "ArticleIdList": ["10.3390/toxins9030103", "PMC5371858", "28335411"]}, {"Citation": "Higgins D., Mann K. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles. J. Biol. Chem. 1983;258:6503\u20136508. doi: 10.1016/S0021-9258(18)32440-2.", "ArticleIdList": ["10.1016/S0021-9258(18)32440-2", "6406482"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "5", "Day": "17"}, {"Year": "2021", "Month": "6", "Day": "23"}, {"Year": "2021", "Month": "6", "Day": "23"}, {"Year": "2021", "Month": "7", "Day": "2", "Hour": "1", "Minute": "2"}, {"Year": "2021", "Month": "7", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["34199017", "PMC8267730", "10.3390/ijms22136896", "ijms22136896"]}}], "PubmedBookArticle": []}